Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
Clinical trial NCT07220785 · RECRUITING
Trial details
- NCT number
- NCT07220785
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-13
- Primary completion
- 2028-05-19
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.